Comparison of secular trends in pneumococcal serotypes causing invasive disease in Denver, Colorado (1971-2004) and

D Akduman1, J M Ehret, F N Judson

  • 1Zonguldak Karaelmas University, Faculty of Medicine, Department of Infectious Diseases and Clinical Microbiology, Zonguldak, Turkey.

Insights

Pneumococcal serotypes in Denver showed shifts over 30 years. While vaccines cover most strains, specific serotypes like 14, 3, 6, 9, and 19 require ongoing surveillance for effective prevention.

Area of Science:

  • Microbiology
  • Epidemiology
  • Vaccinology

Background:

  • Invasive pneumococcal disease (IPD) remains a significant public health concern.
  • Serotype distribution of Streptococcus pneumoniae is dynamic and can vary geographically and temporally.
  • Understanding serotype prevalence is crucial for evaluating vaccine effectiveness and guiding public health strategies.

Purpose of the Study:

  • To analyze the temporal trends of pneumococcal serotypes causing invasive infections in Denver, Colorado, from 1971 to 2004.
  • To assess the coverage of existing pneumococcal vaccines against prevalent serotypes identified during the study period.

Main Methods:

  • Retrospective analysis of invasive pneumococcal isolates from three Denver hospitals.
  • Serotyping of isolates collected between 1971 and 2004.
  • Comparison of serotype prevalence across different time periods and assessment of vaccine coverage.

Main Results:

  • Streptococcus pneumoniae serotype 14 was the most common (13.2%), followed by serotypes 3, 4, 6, 9, and 19 (44.1% combined).
  • Pneumococcal polysaccharide vaccine (PPSV) covered all prevalent serotypes (91.3% of isolates), while pneumococcal conjugate vaccine (PCV) covered 79.1% of prevalent serotypes (56.7% of isolates).
  • Serotypes 6, 9, and 14 showed increased prevalence in the last decade (37.3%) compared to the first (20.2%), while serotypes 3 and 23 decreased (18.5% vs. 11.0%).

Conclusions:

  • Significant shifts in pneumococcal serotype prevalence occurred in Denver between 1971 and 2004.
  • While current vaccines offer broad coverage, the changing epidemiology necessitates ongoing monitoring.
  • The rise of specific serotypes highlights the need for updated vaccination strategies and continued surveillance.

Related Concept Videos

Atypical Pneumonia01:14

Atypical Pneumonia

Atypical pneumonia, often caused by Mycoplasma pneumoniae, is a form of pulmonary infection that differs from the classical presentation of bacterial pneumonia in both its cause and clinical symptoms. Mycoplasma pneumoniae is a pleomorphic bacterium notable for its lack of a rigid cell wall. This structural characteristic imparts resistance to beta-lactam antibiotics and significantly influences the bacterium’s behavior within the human host.Other pathogens responsible for the disease include...
Infectious Diseases and Their Occurrence01:28

Infectious Diseases and Their Occurrence

Infectious diseases appear in populations through various transmission patterns, influenced by pathogen characteristics, population immunity, environmental conditions, and social behavior. Understanding these patterns is essential for effective public health surveillance and intervention. These categories—sporadic, outbreak, epidemic, pandemic, and endemic—help frame the nature and scope of disease events.Sporadic diseases occur irregularly and infrequently, without a predictable temporal or...
Pneumonia I: Introduction01:29

Pneumonia I: Introduction

Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following: